4.6 Article

Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans

Journal

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume 38, Issue 11, Pages 2041-2052

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/0271678X17724947

Keywords

Brain imaging; kinetic modeling; neurodegeneration; positron emission tomography; synapses/dendrites

Funding

  1. UCB Pharma
  2. Swedish Research Council
  3. CTSA from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000142]

Ask authors/readers for more resources

Synaptic vesicle glycoprotein 2A (SV2A) is ubiquitously present in presynaptic terminals. Here we report kinetic modeling and test-retest reproducibility assessment of the SV2A positron emission tomography (PET) radioligand [C-11]UCB-J in humans. Five volunteers were examined twice on the HRRT after bolus injection of [C-11]UCB-J. Arterial blood samples were collected for measurements of radiometabolites and free fraction. Regional time-activity curves were analyzed with 1-tissue (1T) and 2-tissue (2T) compartment models to estimate volumes of distribution (V-T). Parametric maps were generated using the 1T model. [C-11]UCB-J metabolized fairly quickly, with parent fraction of 36 +/- 13% at 15 min after injection. Plasma free fraction was 32 +/- 1%. Regional time-activity curves displayed rapid kinetics and were well described by the 1T model, except for the cerebellum and hippocampus. V-T values estimated with the 2T model were similar to 1T values. Parametric maps were of high quality and V-T values correlated well with time activity curve (TAC)-based estimates. Shortening of acquisition time from 120 min to 60 min had a negligible effect on V-T values. The mean absolute test-retest reproducibility for V-T was 3-9% across regions. In conclusion, [C-11]UCB-J exhibited excellent PET tracer characteristics and has potential as a general purpose tool for measuring synaptic density in neurodegenerative disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available